Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...
Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in respiratory syncytial virus (RSV). The drugmaker is in the ...
The Novartis study was specifically in patients who had received prior novel hormonal therapy (NHT) before the mCRPC stage and randomized them to receive a switch of NHT or Pluvicto. The Pfizer ...
A phase 3 trial found that a combination of a Pfizer and Astellas drug, enfortumab vedotin, and Merck's drug, pembrolizumab, has significantly improved survival rates for patients with advanced ...
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
The trial is already fully enrolled in the Northern Hemisphere—with the first patient dosed last ... up as a side effect in trials for RSV vaccines like Pfizer’s Abrysvo and GSK’s Arexvy.
and respiratory syncytial virus (RSV) become "more prevalent". "In December alone, nearly 740 patients contacted their GP in Yeovil with respiratory concerns - far exceeding the usual numbers we ...
When it's time to choose a vet's office, there are a few things you look for. Reviews and credentials are paramount. Location and price are usually a plus. Cool resident animal is nice, but not a must ...
After hours: February 14 at 7:59:58 PM EST Loading Chart for PFE ...
This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis. RSV occurs in epidemics almost every winter. People do not develop life-long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback